High performance and widely accessible secretomics assay platform
高性能且广泛使用的分泌组学检测平台
基本信息
- 批准号:10547532
- 负责人:
- 金额:$ 94.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-17 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgingAntibodiesBiologicalBiological AssayBiologyBiomedical ResearchCell secretionCellsCoculture TechniquesColorCommunicationComplexComputer softwareDataDetectionDevelopmentDiagnosticDiseaseFluorescein-5-isothiocyanateFluorescenceFutureHealthHeterogeneityHuman Cell LineImmunoassayIndividualLasersMeasurementMeasuresPatternPerformancePeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologic SubstancePhenotypePlayProceduresProteinsReaderReadingRegulationReproducibilityResearch PersonnelResolutionRoleSamplingSet proteinSignal TransductionSlideStainsStreptavidinSystemTechniquesTechnologyTestingTimeWorkantibody conjugateautomated analysisbasebiological systemscell typecostcyanine dye 5designenzyme linked immunospot assayexosomeexperimental studynoveloptical spectraplasmonicsprecision medicineprototypescale upsecretory proteintool
项目摘要
Abstract
Secretory proteins are fundamental to local and systemic cellular signaling in biological systems.
The regulation and dysregulation of the networks involving these proteins plays a critical role in
health, aging, and development of disease. As such, study of these proteins and their networks
is critical to our understanding of biology. Not surprisingly, this particular set of proteins constitutes
a large proportion of the targets of pharmaceutical drugs, and also represents attractive targets
for diagnostics and future precision medicine efforts. Unfortunately, many of these secreted
proteins are difficult to detect. There are existing technologies for studying these secreted proteins
but they either underperform, are extremely expensive and/or complex given their specific-utility.
containing multiple cell types. Although the need to study secreted proteins is ubiquitous, there
is not a technology that is widely available (inexpensive) and capable of providing
information on multiple secreted proteins simultaneously at single-cell resolution, and we
aim to address this need in the current project.
At the core of our technologies is the Plasmonic Fluor (PF), our proprietary, ultrabright
fluorescent nanoconstruct designed to enhance the performance of fluorescence-based
immunoassays. We have already built a high-sensitivity, multiplexed immunoassay platform
leveraging this technology, which is currently being tested with external collaborators. This
platform includes an inexpensive, high performance, single-laser fluorescence microplate/slide
reader optimized for use with our PFs. We will extend this existing platform to accommodate PF-
enhanced cellular secretion assays we call PFluorospot. The upgraded platform that will result
from the proposed effort will be a truly versatile and powerful tool for the measurement of
proteins.
In our preliminary work, we have successfully manufactured at commercial scale and with high
reproducibility streptavidin-conjugated PFs that are spectrally equivalent to FITC, Cy3, and Cy5
(PF490, PF550, and PF650, respectively). We have also created three PFs with entirely unique
excitation/emission spectra: two which have excitation spectra like FITC and emit like Cy3 and
Cy5 (PF490_550 and PF490_650, respectively), and one which has an excitation spectrum like Cy3 but
emits like Cy5 (PF550_650). These unique PFs were synthesized at a prototype scale which we aim
to scale up in this effort because they will allow 3 lasers to be used to interrogate 6 separate
targets. In a demonstration of applicability to cellular secretion assays, streptavidin-PF550 and
PF650 were conjugated to antibodies at a small scale and used to perform dual-color PFluorospot.
These initial PFluorospot experiments show that additional information can be obtained in these
assays relative to ELISPOT/FluoroSpot, and are simpler and significantly faster to perform. It was
possible to visualize individual cells for adherent cells and better localize secreting cells. This is
particularly important for understanding heterogeneity, spatial effects in co-culture, and
polyfunctionality, and we propose to add a 4th laser to our reader to accommodate cell markers.
Additionally, a single-color PFluorospot assay was read with our existing reader and
demonstrated high sensitivity, high resolution, and short read times.
We believe our Pfluorospot platform and reader will become the go-to secretomics platform, and
will empower many more biological researchers to measure important, secreted proteins.
抽象的
分泌蛋白是生物系统中局部和全身细胞信号的基础。
涉及这些蛋白质的网络的调节和失调在
疾病的健康,衰老和发展。因此,研究这些蛋白质及其网络
对于我们对生物学的理解至关重要。毫不奇怪,这组蛋白质构成
药物的大部分靶标,也代表有吸引力的靶标
用于诊断和未来的精密医学工作。不幸的是,其中许多分泌
蛋白质难以检测。现有的技术用于研究这些分泌的蛋白质
但是,鉴于它们的特殊性,他们要么表现不佳,要么非常昂贵和/或复杂。
包含多种细胞类型。尽管需要研究分泌蛋白的需求无处不在,但
不是一项广泛可用(廉价)并且能够提供的技术
单细胞分辨率同时了解多种分泌蛋白的信息,我们
旨在解决当前项目中的这一需求。
我们技术的核心是等离激子荧光(PF),我们的专有,Ultrabright
荧光纳米构造旨在增强基于荧光的性能
免疫测定。我们已经建立了高敏性,多重免疫测定平台
利用这项技术,该技术目前正在与外部合作者进行测试。这
平台包括廉价的高性能,单重荧光微板/幻灯片
读取器优化用于我们的PFS。我们将扩展此现有平台以适应PF-
增强的细胞分泌测定法,我们称为Pfluorospot。将导致的升级平台
从拟议的工作中,将是一个真正多才多艺的强大工具,用于测量
蛋白质。
在我们的初步工作中,我们已经成功地以商业规模制造,并且很高
可重复性链霉亲和素偶联的PF,在频谱上等效于FITC,CY3和CY5
(PF490,PF550和PF650)。我们还创建了三个完全独特的PF
激发/发射光谱:两个具有激发光谱,例如FITC,并像CY3一样发射
Cy5(分别为PF490_550和PF490_650),并且具有像CY3一样激发频谱
发出例如CY5(PF550_650)。这些独特的PF是按原型量表合成的
在这项工作中扩大规模,因为它们将允许3个激光器分开询问6个激光器
目标。为了证明适用于细胞分泌测定的适用性,链霉亲和素Pf550和
将PF650与小型抗体结合在一起,并用于执行双色Pfluorospot。
这些最初的pfluorospot实验表明,可以在其中获得其他信息
相对于ELISPOT/Fluorospot的测定,执行更简单,更明显。是
可能可视化单个细胞的粘附细胞并更好地定位分泌细胞。这是
对于理解异质性,在共文化中的空间效应以及
多功能性,我们建议向读者添加第四激光以适应细胞标记。
此外,我们现有的读者和
表现出高灵敏度,高分辨率和简短的阅读时间。
我们认为,我们的Pfluorospot平台和读者将成为首选的秘密平台,以及
将使更多更多的生物学研究人员能够测量重要的分泌蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott L Crick其他文献
Scott L Crick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott L Crick', 18)}}的其他基金
High performance and widely accessible secretomics assay platform
高性能且广泛使用的分泌组学检测平台
- 批准号:
10705734 - 财政年份:2022
- 资助金额:
$ 94.35万 - 项目类别:
Ultrabright Fluorescent Nanoconstruct Enabling Widely Accessible, High Performance Multiplexed Protein Assays
超亮荧光纳米结构实现广泛可及的高性能多重蛋白质检测
- 批准号:
10194377 - 财政年份:2020
- 资助金额:
$ 94.35万 - 项目类别:
A High Sensitivity Multiplexed Immunoassay for Aging-Related Inflammation Biomarker Quantification
用于衰老相关炎症生物标志物定量的高灵敏度多重免疫测定
- 批准号:
9909594 - 财政年份:2020
- 资助金额:
$ 94.35万 - 项目类别:
Ultrabright Fluorescent Nanoconstruct Enabling Widely Accessible, High Performance Multiplexed Protein Assays
超亮荧光纳米结构实现广泛可及的高性能多重蛋白质检测
- 批准号:
10080340 - 财政年份:2020
- 资助金额:
$ 94.35万 - 项目类别:
Modulation of Amyloid-Beta Aggregation in the Endosomal/Lysosomal Pathway
内体/溶酶体途径中淀粉样蛋白-β 聚集的调节
- 批准号:
8453848 - 财政年份:2013
- 资助金额:
$ 94.35万 - 项目类别:
Modulation of Amyloid-Beta Aggregation in the Endosomal/Lysosomal Pathway
内体/溶酶体途径中淀粉样蛋白-β 聚集的调节
- 批准号:
8665815 - 财政年份:2013
- 资助金额:
$ 94.35万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 94.35万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 94.35万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 94.35万 - 项目类别:
Molecular Tool Development to Identify, Isolate, and Interrogate the Rod Microglia Phenotype in Neurological Disease and Injury
开发分子工具来识别、分离和询问神经系统疾病和损伤中的杆状小胶质细胞表型
- 批准号:
10599762 - 财政年份:2023
- 资助金额:
$ 94.35万 - 项目类别:
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 94.35万 - 项目类别: